These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33033167)

  • 1. Diffusion imaging in Huntington's disease: comprehensive review.
    Estevez-Fraga C; Scahill R; Rees G; Tabrizi SJ; Gregory S
    J Neurol Neurosurg Psychiatry; 2020 Oct; 92(1):62-9. PubMed ID: 33033167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive alterations in white matter microstructure across the timecourse of Huntington's disease.
    Estevez-Fraga C; Elmalem MS; Papoutsi M; Durr A; Rees EM; Hobbs NZ; Roos RAC; Landwehrmeyer B; Leavitt BR; Langbehn DR; Scahill RI; Rees G; Tabrizi SJ; Gregory S
    Brain Behav; 2023 Apr; 13(4):e2940. PubMed ID: 36917716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo characterization of white matter pathology in premanifest huntington's disease.
    Zhang J; Gregory S; Scahill RI; Durr A; Thomas DL; Lehericy S; Rees G; Tabrizi SJ; Zhang H;
    Ann Neurol; 2018 Oct; 84(4):497-504. PubMed ID: 30063250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Diffusion Tensor Imaging Shows Progressive Changes in White Matter in Huntington's Disease.
    Gregory S; Cole JH; Farmer RE; Rees EM; Roos RA; Sprengelmeyer R; Durr A; Landwehrmeyer B; Zhang H; Scahill RI; Tabrizi SJ; Frost C; Hobbs NZ
    J Huntingtons Dis; 2015; 4(4):333-46. PubMed ID: 26756590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study.
    Poudel GR; Stout JC; Domínguez D JF; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
    Neurobiol Dis; 2015 Feb; 74():406-12. PubMed ID: 25497085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Imaging Markers to Track Huntington's Disease Pathology.
    Wilson H; De Micco R; Niccolini F; Politis M
    Front Neurol; 2017; 8():11. PubMed ID: 28194132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease.
    Dumas EM; van den Bogaard SJ; Ruber ME; Reilman RR; Stout JC; Craufurd D; Hicks SL; Kennard C; Tabrizi SJ; van Buchem MA; van der Grond J; Roos RA
    Hum Brain Mapp; 2012 Jan; 33(1):203-12. PubMed ID: 21264990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microstructural brain abnormalities in Huntington's disease: A two-year follow-up.
    Odish OF; Leemans A; Reijntjes RH; van den Bogaard SJ; Dumas EM; Wolterbeek R; Tax CM; Kuijf HJ; Vincken KL; van der Grond J; Roos RA
    Hum Brain Mapp; 2015 Jun; 36(6):2061-74. PubMed ID: 25644819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating longitudinal changes to frontal cortico-striatal tracts in Huntington's disease: the IMAGE-HD study.
    Tan B; Shishegar R; Oldham S; Fornito A; Poudel G; Georgiou-Karistianis N
    Brain Imaging Behav; 2022 Dec; 16(6):2457-2466. PubMed ID: 35768755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-compartment analysis of the complex gradient-echo signal quantifies myelin breakdown in premanifest Huntington's disease.
    Casella C; Kleban E; Rosser AE; Coulthard E; Rickards H; Fasano F; Metzler-Baddeley C; Jones DK
    Neuroimage Clin; 2021; 30():102658. PubMed ID: 33865029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter predicts functional connectivity in premanifest Huntington's disease.
    McColgan P; Gregory S; Razi A; Seunarine KK; Gargouri F; Durr A; Roos RA; Leavitt BR; Scahill RI; Clark CA; Tabrizi SJ; Rees G; ; Coleman A; Decolongon J; Fan M; Petkau T; Jauffret C; Justo D; Lehericy S; Nigaud K; Valabrègue R; Choonderbeek A; Hart EP; Hensman Moss DJ; Crawford H; Johnson E; Papoutsi M; Berna C; Reilmann R; Weber N; Stout J; Labuschagne I; Landwehrmeyer B; Orth M; Johnson H
    Ann Clin Transl Neurol; 2017 Feb; 4(2):106-118. PubMed ID: 28168210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary examination of early neuroconnectivity features in the R6/1 mouse model of Huntington's disease by ultra-high field diffusion MRI.
    Gatto RG; Weissmann C
    Neural Regen Res; 2022 May; 17(5):983-986. PubMed ID: 34558512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington's disease.
    McColgan P; Seunarine KK; Gregory S; Razi A; Papoutsi M; Long JD; Mills JA; Johnson E; Durr A; Roos RA; Leavitt BR; Stout JC; Scahill RI; Clark CA; Rees G; Tabrizi SJ;
    JCI Insight; 2017 Apr; 2(8):. PubMed ID: 28422761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter connectivity reflects clinical and cognitive status in Huntington's disease.
    Poudel GR; Stout JC; Domínguez D JF; Salmon L; Churchyard A; Chua P; Georgiou-Karistianis N; Egan GF
    Neurobiol Dis; 2014 May; 65():180-7. PubMed ID: 24480090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington's disease.
    McColgan P; Seunarine KK; Razi A; Cole JH; Gregory S; Durr A; Roos RA; Stout JC; Landwehrmeyer B; Scahill RI; Clark CA; Rees G; Tabrizi SJ;
    Brain; 2015 Nov; 138(Pt 11):3327-44. PubMed ID: 26384928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huntington's disease: Brain imaging in Huntington's disease.
    Johnson EB; Gregory S
    Prog Mol Biol Transl Sci; 2019; 165():321-369. PubMed ID: 31481169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fixel-Based Analysis Effectively Identifies White Matter Tract Degeneration in Huntington's Disease.
    Oh SL; Chen CM; Wu YR; Valdes Hernandez M; Tsai CC; Cheng JS; Chen YL; Wu YM; Lin YC; Wang JJ
    Front Neurosci; 2021; 15():711651. PubMed ID: 34588947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures.
    Rosas HD; Tuch DS; Hevelone ND; Zaleta AK; Vangel M; Hersch SM; Salat DH
    Mov Disord; 2006 Sep; 21(9):1317-25. PubMed ID: 16755582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the order and pattern of brain structural MRI changes using change-point analysis in premanifest Huntington's disease.
    Wu D; Faria AV; Younes L; Mori S; Brown T; Johnson H; Paulsen JS; Ross CA; Miller MI;
    Hum Brain Mapp; 2017 Oct; 38(10):5035-5050. PubMed ID: 28657159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing White Matter in Huntington's Disease.
    Gregory S; Johnson E; Byrne LM; Rodrigues FB; Henderson A; Moss J; Thomas D; Zhang H; De Vita E; Tabrizi SJ; Rees G; Scahill RI; Wild EJ
    Mov Disord Clin Pract; 2020 Jan; 7(1):52-60. PubMed ID: 31970212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.